Esterbauer H. , Zollner H., Schaur RJ: Hydroxyalkenals: Cytotoxic products of lipid peroxidation. Res Rev Biochem1:311-315, 1988
3.
Fridovich I. : Superoxide dismutases. Adv Enzymol41:35-48, 1974
4.
Halliwell B. , Gutteridge JMC : Free Radicals in Biology and Medicine, 2nd ed. Clarendon Press, Oxford, 1989
5.
Furchgott RF , Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature288:373, 1980
6.
Marletta M.: Nitric oxide: Biosynthesis and biological significance. TIBS14:488-492, 1989
7.
Thomas G., Ramwell PW: N-Oxygenation and mechanism of endothelium-dependent relaxation. Clin Res38:403A, 1990.
8.
Kuehl F., Humes JL, Egan RW, et al: Role of prostaglandin endoperoxide PGG2 in inflammatory processes . Nature265:170-173, 1977
9.
Moncada S., Ferreira SH, Vane JR: Inhibition of prostaglandin biosynthesis as the mechanism of analgesia of aspirin-like drugs in the dog knee joint. Eur J Pharmacol31:250-260, 1975
10.
Foegh ML: Eicosanoids and platelet activating factor mechanisms in organ rejection . Transpl Proc20:1260-1263, 1988
11.
Foegh ML, Alijani MR, Helfrich GB, et al: Fatty acids and eicosanoids in organ transplantation. Prog Lipid Res25:567-573, 1986
12.
Dennis EA: The regulation of eicosanoid production. Biochem Tech5:1294-1300, 1987
13.
Dyerberg J. , Bang HO: Lipid metabolism, atherogenesis, and hemostasis in Eskimos: The role of the prostaglandin-3 family. Haemostasis8:227-233, 1979
14.
Kromhout D. , Bosschieter EB, de Lezenne Coulander C.: The inverse relation between fish consumption and 20-year mortality from coronary heart disease . N Engl J Med312:1205-1209, 1985
15.
Shekelle RB , Gale M., Norusis M.: Type A score (Jenkins Activity Survey) and risk of recurrent coronary heart disease in the aspirin infarction study. Am J Cardiol56:221-225, 1985
16.
Knapp HR, Reilly IAG, Alessandrini P., et al: In vitro indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med314:937-942, 1986
17.
Knapp HR, Fitzgerald GA: The antihypertensive effects of fish oil. N Engl J Med320:1037-1043, 1989
18.
Sarris GE, Mitchell RS, Billingham ME, et al: Inhibition of accelerated cardiac allograft arteriosclerosis by fish oil. J Thorac Cardiovasc Surg97:841-855, 1989
19.
McHugh MI, Wilkinson R., Elliott RW, et al: Immunosuppression with polyunsaturated fatty acids in renal transplantation. Transplantation24:263-267, 1977
20.
Schreiner GF , Flye W., Brunt E., et al: Essential fatty acid depletion of renal allografts and prevention of rejection. Science240:1032-1033, 1988
21.
Kettle AJ, Winterbourn CC: Superoxide modulates the activity of myeloperoxidase and optimizes the production of hypochlorous acid. Biochem J252:529-536, 1988
22.
Conte JV, Foegh ML: Lung preservation: A new indication for a PAF antagonist, BN 52021 . IN PAF Antagonists, New Developments for Clinical Application , O'Flaherty JP, Ramwell PW (eds). Portfolio Publishing Co., The Woodlands, TX, 1990, pp 129-137
23.
Conte JV, Katz NM, Foegh ML, et al: Iron chelation therapy and lung transplantation: The effects of deferoxamine on lung preservation in canine single-lung transplantation . J Cardiovasc Surg, in press
